Similar articles

• Metabolism of chemical carcinogens.

  Dipple A, Michejda CJ, Weisburger EK. Dipple A, et al. Pharmacol Ther. 1985;27(3):265-96. doi: 10.1016/0163-7258(85)90072-5. Pharmacol Ther. 1985. PMID: 3931106 Review. No abstract available.
• Binding of polycyclic aromatic hydrocarbons to DNA: comparison with mutagenesis and tumorigenesis.

  Pelkonen O, Vähäkangas K, Nebert DW. Pelkonen O, et al. J Toxicol Environ Health. 1980 Sep-Nov;6(5-6):1009-20. doi: 10.1080/15287398009529923. J Toxicol Environ Health. 1980. PMID: 7463499 No abstract available.
• Metabolism and activation of carcinogenic polycyclic hydrocarbons by human mammary cells.

  MacNicoll AD, Easty GC, Neville AM, Grover PL, Sims P. MacNicoll AD, et al. Biochem Biophys Res Commun. 1980 Aug 29;95(4):1599-606. doi: 10.1016/s0006-291x(80)80081-7. Biochem Biophys Res Commun. 1980. PMID: 6774726 No abstract available.
• Metabolic activation of polycyclic aromatic carcinogens: a theoretical study.

  Umans RS, Koruda M, Sardella DJ. Umans RS, et al. Mol Pharmacol. 1979 Sep;16(2):633-42. Mol Pharmacol. 1979. PMID: 514263 No abstract available.
• DNA and hemoglobin adducts as markers of metabolic activation of tobacco-specific carcinogens.

  Foiles PG, Murphy SE, Peterson LA, Carmella SG, Hecht SS. Foiles PG, et al. Cancer Res. 1992 May 1;52(9 Suppl):2698s-2701s. Cancer Res. 1992. PMID: 1563001 Review.